体重损失注射表明,通过减少大脑炎症,研究发现,在改善心理健康方面有希望。 Weight-loss injections show promise in improving mental health by reducing brain inflammation, studies find.

欧洲肥胖症大会的研究人员发现,称为GLP-1受体激动剂的减重注射可以通过减少脑炎,改善心理健康和福利。 Researchers at the European Congress on Obesity found that weight-loss injections, known as GLP-1 receptor agonists, can improve mental health and wellbeing by reducing brain inflammation. 这些最初为糖尿病设计的药物在提高情绪和生活质量的研究中有所显示,甚至可以防止痴呆。 These medications, originally designed for diabetes, have shown in studies to enhance mood and quality of life, and may even protect against dementia. 皇家精神病学学院建议优先为精神病患者提供这些药物,因为它们能够抵消精神病药物造成的体重增加。 The Royal College of Psychiatrists recommends prioritizing these drugs for patients with mental illness, as they can counteract weight gain caused by psychiatric medications. 研究表明,这些注射不会使心理健康恶化,并可能使那些患有严重精神紊乱症的人受益,因为他们更可能肥胖。 Studies suggest these injections do not worsen mental health and could benefit those with severe mental disorders, who are more likely to be obese.